The medical economic effects of the Pneumococcal vaccine in the elderly.

UMIN ID: UMIN000001681

Registered date:01/03/2009

Basic Information

• Recruitment status: Complete: follow-up complete
• Health condition(s) or Problem(s) studied: Community-acquired pneumonia in the elderly
• Date of first enrollment: 2009/05/01
• Target sample size: 200
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

Pneumococcal vaccination
without Pneumococcal vaccination

Outcome(s)

• Primary Outcome: Incidence of pneumonia
• Secondary Outcome: Medical costs

Key inclusion & exclusion criteria

• Age minimum: 65years-old
• Age maximum: 90years-old
• Gender: Male and Female
• Exclude criteria: 1) patients who have already received Pneumococcal vaccine. 2) patients who are receiving radiation therapy 3) patients who are given an immunosuppressive drug 4) patients who have fever 5) patients with a malignant neoplasm 6) patients with a severe disease in liver, kidney, heart, or lung 7) when the doctor decides the patient's condition is inappropriate

Related Information

• Primary Sponsor: Department of Advanced Preventive Medicine for Infectious Disease, Tohoku University School of Medicine
• Source(s) of Monetary Support: Scholarship donation